# Genesco Inc: financial statements, quarterly GCO · NYSE · CIK 18498 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30 Pages: [Overview](/companies/gco.md) · [Financials](/companies/gco/financials.md) · [Filings](/companies/gco/filings.md) · [Insiders](/companies/gco/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gco/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2024 (2023-10-28) | Q4 FY2024 (2024-02-03) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | Q4 FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [579](/filings/0000950170-24-135629.md) | [739 d](/filings/0001193125-26-123492.md) | [458](/filings/0000950170-25-085164.md) | [525](/filings/0000950170-25-114115.md) | [596](/filings/0001193125-25-315336.md) | [746 d](/filings/0001193125-26-123492.md) | [474](/filings/0001193125-26-266889.md) | [546](/filings/0001193125-26-387556.md) | [616](/filings/0001193125-25-315336.md) | [800 d](/filings/0001193125-26-123492.md) | [487](/filings/0001193125-26-266889.md) | [530](/filings/0001193125-26-387556.md) | | Cost of revenue | $m | [301](/filings/0000950170-24-135629.md) | [397 d](/filings/0001193125-26-123492.md) | [241](/filings/0000950170-25-085164.md) | [280](/filings/0000950170-25-114115.md) | [311](/filings/0001193125-25-315336.md) | [396 d](/filings/0001193125-26-123492.md) | [253](/filings/0001193125-26-266889.md) | [296](/filings/0001193125-26-387556.md) | [328](/filings/0001193125-25-315336.md) | [433 d](/filings/0001193125-26-123492.md) | [258](/filings/0001193125-26-266889.md) | [258](/filings/0001193125-26-387556.md) | | Gross profit | $m | [278](/filings/0000950170-24-135629.md) | [342 d](/filings/0001193125-26-123492.md) | [216](/filings/0000950170-25-085164.md) | [246](/filings/0000950170-25-114115.md) | [285](/filings/0001193125-25-315336.md) | [350 d](/filings/0001193125-26-123492.md) | [221](/filings/0001193125-26-266889.md) | [250](/filings/0001193125-26-387556.md) | [289](/filings/0001193125-25-315336.md) | [367 d](/filings/0001193125-26-123492.md) | [229](/filings/0001193125-26-266889.md) | [272](/filings/0001193125-26-387556.md) | | Selling, general and administrative | $m | [267](/filings/0000950170-24-135629.md) | [304 d](/filings/0001193125-26-123492.md) | [248](/filings/0000950170-25-085164.md) | [255](/filings/0000950170-25-114115.md) | [275](/filings/0001193125-25-315336.md) | [302 d](/filings/0001193125-26-123492.md) | [249](/filings/0001193125-26-266889.md) | [264](/filings/0001193125-26-387556.md) | [276](/filings/0001193125-25-315336.md) | [312 d](/filings/0001193125-26-123492.md) | [254](/filings/0001193125-26-266889.md) | [260](/filings/0001193125-26-387556.md) | | Operating income | $m | [10.9](/filings/0000950170-24-135629.md) | [37.3 d](/filings/0001193125-26-123492.md) | [(32.1)](/filings/0000950170-25-085164.md) | [(10.3)](/filings/0000950170-25-114115.md) | [10.2](/filings/0001193125-25-315336.md) | [46.1 d](/filings/0001193125-26-123492.md) | [(28.1)](/filings/0001193125-26-266889.md) | [(14.4)](/filings/0001193125-26-387556.md) | [8.6](/filings/0001193125-25-315336.md) | [51.3 d](/filings/0001193125-26-123492.md) | [(15.4)](/filings/0001193125-26-266889.md) | [3.6](/filings/0001193125-26-387556.md) | | Interest expense | $m | [2.2](/filings/0000950170-24-135629.md) | [1.5 d](/filings/0000950170-24-036902.md) | [0.9](/filings/0000950170-24-072730.md) | [1.3](/filings/0000950170-24-105736.md) | [1.2](/filings/0000950170-24-135629.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [1.9](/filings/0000950170-24-135629.md) | [15.3 d](/filings/0001193125-26-123492.md) | [(8.8)](/filings/0000950170-25-085164.md) | [(1.8)](/filings/0000950170-25-114115.md) | [27.8](/filings/0001193125-25-315336.md) | [11.7 d](/filings/0001193125-26-123492.md) | [(8.5)](/filings/0001193125-26-266889.md) | [2.4](/filings/0001193125-26-387556.md) | [2.1](/filings/0001193125-25-315336.md) | [3.2 d](/filings/0001193125-26-123492.md) | [(1.1)](/filings/0001193125-26-266889.md) | [(0.1)](/filings/0001193125-26-387556.md) | | Net income | $m | [6.5](/filings/0000950170-24-135629.md) | [27.2 d](/filings/0001193125-26-123492.md) | [(24.3)](/filings/0001193125-25-315336.md) | [(10.0)](/filings/0001193125-25-315336.md) | [(18.9)](/filings/0001193125-25-315336.md) | [34.4 d](/filings/0001193125-26-123492.md) | [(21.2)](/filings/0001193125-26-387556.md) | [(18.5)](/filings/0001193125-26-387556.md) | [5.4](/filings/0001193125-25-315336.md) | [47.6 d](/filings/0001193125-26-123492.md) | [(14.8)](/filings/0001193125-26-387556.md) | [3.5](/filings/0001193125-26-387556.md) | | Diluted EPS | $ per share | [0.60](/filings/0000950170-24-135629.md) | not reported | [(2.23)](/filings/0000950170-25-085164.md) | [(0.91)](/filings/0000950170-25-114115.md) | [(1.76)](/filings/0001193125-25-315336.md) | not reported | [(2.02)](/filings/0001193125-26-266889.md) | [(1.79)](/filings/0001193125-26-387556.md) | [0.50](/filings/0001193125-25-315336.md) | not reported | [(1.42)](/filings/0001193125-26-266889.md) | [0.32](/filings/0001193125-26-387556.md) | | Basic EPS | $ per share | [0.60](/filings/0000950170-24-135629.md) | not reported | [(2.23)](/filings/0000950170-25-085164.md) | [(0.91)](/filings/0000950170-25-114115.md) | [(1.76)](/filings/0001193125-25-315336.md) | not reported | [(2.02)](/filings/0001193125-26-266889.md) | [(1.79)](/filings/0001193125-26-387556.md) | [0.52](/filings/0001193125-25-315336.md) | not reported | [(1.42)](/filings/0001193125-26-266889.md) | [0.33](/filings/0001193125-26-387556.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2024 (2023-10-28) | FY2024 (2024-02-03) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [21.7](/filings/0000950170-24-135629.md) | [35.2](/filings/0000950170-25-044864.md) | [19.2](/filings/0000950170-25-085164.md) | [45.9](/filings/0000950170-25-114115.md) | [33.6](/filings/0001193125-25-315336.md) | [34.0](/filings/0001193125-26-123492.md) | [21.7](/filings/0001193125-26-266889.md) | [41.0](/filings/0001193125-26-387556.md) | [27.0](/filings/0001193125-25-315336.md) | [105](/filings/0001193125-26-387556.md) | [27.1](/filings/0001193125-26-266889.md) | [57.1](/filings/0001193125-26-387556.md) | | Current assets | $m | [639](/filings/0000950170-24-135629.md) | [507](/filings/0000950170-25-044864.md) | [508](/filings/0000950170-25-085164.md) | [607](/filings/0000950170-25-114115.md) | [660](/filings/0001193125-25-315336.md) | [609](/filings/0001193125-26-123492.md) | [633](/filings/0001193125-26-266889.md) | [646](/filings/0001193125-26-387556.md) | [689](/filings/0001193125-25-315336.md) | [619](/filings/0001193125-26-387556.md) | [596](/filings/0001193125-26-266889.md) | [676](/filings/0001193125-26-387556.md) | | Total assets | $m | [1,493](/filings/0000950170-24-135629.md) | [1,330](/filings/0001193125-26-123492.md) | [1,307](/filings/0000950170-25-085164.md) | [1,384](/filings/0000950170-25-114115.md) | [1,436](/filings/0001193125-25-315336.md) | [1,336](/filings/0001193125-26-123492.md) | [1,405](/filings/0001193125-26-266889.md) | [1,422](/filings/0001193125-26-387556.md) | [1,472](/filings/0001193125-25-315336.md) | [1,393](/filings/0001193125-26-387556.md) | [1,384](/filings/0001193125-26-266889.md) | [1,504](/filings/0001193125-26-387556.md) | | Current liabilities | $m | [397](/filings/0000950170-24-135629.md) | [320](/filings/0000950170-25-044864.md) | [308](/filings/0000950170-25-085164.md) | [396](/filings/0000950170-25-114115.md) | [422](/filings/0001193125-25-315336.md) | [380](/filings/0001193125-26-123492.md) | [331](/filings/0001193125-26-266889.md) | [414](/filings/0001193125-26-387556.md) | [436](/filings/0001193125-25-315336.md) | [376](/filings/0001193125-26-387556.md) | [325](/filings/0001193125-26-266889.md) | [427](/filings/0001193125-26-387556.md) | | Total liabilities | $m | [956](/filings/0000950170-24-135629.md) | [759](/filings/0000950170-25-044864.md) | [759](/filings/0000950170-25-085164.md) | [851](/filings/0000950170-25-114115.md) | [919](/filings/0001193125-25-315336.md) | [789](/filings/0001193125-26-123492.md) | [882](/filings/0001193125-26-266889.md) | [916](/filings/0001193125-26-387556.md) | [958](/filings/0001193125-25-315336.md) | [826](/filings/0001193125-26-387556.md) | [832](/filings/0001193125-26-266889.md) | [947](/filings/0001193125-26-387556.md) | | Long-term debt | $m | [128](/filings/0000950170-24-135629.md) | [34.7](/filings/0000950170-25-044864.md) | [59.4](/filings/0000950170-25-085164.md) | [77.8](/filings/0000950170-25-114115.md) | [100](/filings/0001193125-25-315336.md) | [0.0](/filings/0001193125-26-123492.md) | [114](/filings/0001193125-26-266889.md) | [57.7](/filings/0001193125-26-387556.md) | [69.8](/filings/0001193125-25-315336.md) | [3.4](/filings/0001193125-26-387556.md) | [45.3](/filings/0001193125-26-266889.md) | [15.8](/filings/0001193125-26-387556.md) | | Current portion of debt | $m | [0.0](/filings/0000950170-23-068685.md) | not reported | [0.0](/filings/0000950170-25-085164.md) | [0.0](/filings/0000950170-25-114115.md) | [0.0](/filings/0001193125-25-315336.md) | [0.0](/filings/0001193125-25-315336.md) | [7.3](/filings/0001193125-26-266889.md) | [13.3](/filings/0001193125-26-387556.md) | [19.7](/filings/0001193125-25-315336.md) | [0.0](/filings/0001193125-26-387556.md) | [0.0](/filings/0001193125-26-266889.md) | [0.0](/filings/0001193125-26-387556.md) | | Shareholders' equity | $m | [537](/filings/0000950170-24-135629.md) | [571](/filings/0001193125-26-123492.md) | [548](/filings/0001193125-25-315336.md) | [533](/filings/0001193125-25-315336.md) | [517](/filings/0001193125-25-315336.md) | [547](/filings/0001193125-26-387556.md) | [522](/filings/0001193125-26-387556.md) | [506](/filings/0001193125-26-387556.md) | [514](/filings/0001193125-25-315336.md) | [567](/filings/0001193125-26-387556.md) | [552](/filings/0001193125-26-387556.md) | [557](/filings/0001193125-26-387556.md) | - Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2024 (2023-10-28) | Q4 FY2024 (2024-02-03) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | Q4 FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [1.6 d](/filings/0000950170-24-135629.md) | [118 d](/filings/0001193125-26-123492.md) | [(33.7)](/filings/0000950170-25-085164.md) | [27.7 d](/filings/0000950170-25-114115.md) | [(23.1) d](/filings/0001193125-25-315336.md) | [117 d](/filings/0001193125-26-123492.md) | [(101)](/filings/0001193125-26-266889.md) | [86.3 d](/filings/0001193125-26-387556.md) | [(12.9) d](/filings/0001193125-25-315336.md) | [173 d](/filings/0001193125-26-123492.md) | [(103)](/filings/0001193125-26-266889.md) | [76.4 d](/filings/0001193125-26-387556.md) | | Capital expenditure | $m | [14.4 d](/filings/0000950170-24-135629.md) | [10.6 d](/filings/0001193125-26-123492.md) | [6.4](/filings/0000950170-25-085164.md) | [7.9 d](/filings/0000950170-25-114115.md) | [13.1 d](/filings/0001193125-25-315336.md) | [13.7 d](/filings/0001193125-26-123492.md) | [18.9](/filings/0001193125-26-266889.md) | [14.7 d](/filings/0001193125-26-387556.md) | [18.6 d](/filings/0001193125-25-315336.md) | [9.9 d](/filings/0001193125-26-123492.md) | [15.4](/filings/0001193125-26-266889.md) | [16.3 d](/filings/0001193125-26-387556.md) | | Share repurchases | $m | [0.0 d](/filings/0000950170-24-135629.md) | [0.0 d](/filings/0001193125-26-123492.md) | [0.0](/filings/0000950170-25-085164.md) | [9.3 d](/filings/0000950170-25-114115.md) | [0.4 d](/filings/0001193125-25-315336.md) | [0.0 d](/filings/0001193125-26-123492.md) | [12.6](/filings/0001193125-26-266889.md) | [0.0 d](/filings/0001193125-26-387556.md) | [0.0 d](/filings/0001193125-25-315336.md) | [0.0 d](/filings/0001193125-26-123492.md) | [0.0](/filings/0001193125-26-266889.md) | [0.0 d](/filings/0001193125-26-387556.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2023 (2022-10-29) | Q1 FY2024 (2023-04-29) | Q2 FY2024 (2023-07-29) | Q3 FY2024 (2023-10-28) | Q1 FY2025 (2024-05-04) | Q2 FY2025 (2024-08-03) | Q3 FY2025 (2024-11-02) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [12.3](/filings/0000950170-23-068685.md) | [11.8](/filings/0000950170-24-072730.md) | [11.3](/filings/0000950170-24-105736.md) | [11.0](/filings/0000950170-24-135629.md) | [10.9](/filings/0000950170-25-085164.md) | [10.9](/filings/0000950170-25-114115.md) | [10.7](/filings/0001193125-25-315336.md) | [10.5](/filings/0001193125-26-266889.md) | [10.3](/filings/0001193125-26-387556.md) | [10.7](/filings/0001193125-25-315336.md) | [10.4](/filings/0001193125-26-266889.md) | [10.9](/filings/0001193125-26-387556.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 10,820,152 at 2026-08-28, from the cover of the [10-Q filed 2026-09-10](/filings/0001193125-26-387556.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.